Systemic delivery of curcumin: 21st century solutions for an ancient conundrum
S Bisht, A Maitra - Current drug discovery technologies, 2009 - ingentaconnect.com
Curcumin, a polyphenolic compound derived from the dietary spice turmeric, possesses
diverse pharmacologic effects including anti-inflammatory, anti-oxidant, anti-proliferative and …
diverse pharmacologic effects including anti-inflammatory, anti-oxidant, anti-proliferative and …
Novel curcumin oral delivery systems
T Kurita, Y Makino - Anticancer research, 2013 - ar.iiarjournals.org
Curcumin, a natural polyphenolic compound derived from turmeric (Curcuma longa L), has
proven to be a modulator of multiple intercellular signalling pathways linked to inflammation …
proven to be a modulator of multiple intercellular signalling pathways linked to inflammation …
Conundrum and therapeutic potential of curcumin in drug delivery
Turmeric, the source of the polyphenolic active compound curcumin (diferuloylmethane),
has been used extensively in traditional medicine since ancient times as a household …
has been used extensively in traditional medicine since ancient times as a household …
Bioavailability of curcumin: problems and promises
P Anand, AB Kunnumakkara, RA Newman… - Molecular …, 2007 - ACS Publications
Curcumin, a polyphenolic compound derived from dietary spice turmeric, possesses diverse
pharmacologic effects including anti-inflammatory, antioxidant, antiproliferative and …
pharmacologic effects including anti-inflammatory, antioxidant, antiproliferative and …
[HTML][HTML] Improving curcumin bioavailability: Current strategies and future perspectives
R Tabanelli, S Brogi, V Calderone - Pharmaceutics, 2021 - mdpi.com
Curcumin possesses a plethora of interesting pharmacological effects. Unfortunately, it is
also characterized by problematic drug delivery and scarce bioavailability, representing the …
also characterized by problematic drug delivery and scarce bioavailability, representing the …
[HTML][HTML] Biomedical applications and bioavailability of curcumin—An updated overview
Curcumin, a yellow-colored molecule derived from the rhizome of Curcuma longa, has been
identified as the bioactive compound responsible for numerous pharmacological activities of …
identified as the bioactive compound responsible for numerous pharmacological activities of …
Pharmacological and clinical properties of curcumin
CS Beevers, S Huang - Botanics: Targets and Therapy, 2011 - Taylor & Francis
The polyphenol natural product curcumin has been the subject of numerous studies over the
past decades, which have identified and characterized the compound's pharmacokinetic …
past decades, which have identified and characterized the compound's pharmacokinetic …
An update on the pharmacological usage of curcumin: has it failed in the drug discovery pipeline?
The pharmacological propensities of curcumin have been reported in a plethora of pre-
clinical and clinical studies. However, innate attributes account for extremely low oral …
clinical and clinical studies. However, innate attributes account for extremely low oral …
[HTML][HTML] Curcumin―the paradigm of a multi-target natural compound with applications in cancer prevention and treatment
As cancer is a multifactor disease, it may require treatment with compounds able to target
multiple intracellular components. We summarize here how curcumin is able to modulate …
multiple intracellular components. We summarize here how curcumin is able to modulate …
Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions
J Adiwidjaja, AJ McLachlan… - Expert opinion on drug …, 2017 - Taylor & Francis
Introduction: Curcumin has been extensively studied for its anti-cancer properties. While a
diverse array of in vitro and preclinical research support the prospect of curcumin use as an …
diverse array of in vitro and preclinical research support the prospect of curcumin use as an …